MedTrace Logo

Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)

NCT00219414 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2007-09-27

No results posted yet for this study

Summary

The purpose of the study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.

Conditions

Interventions

DEVICE

Adacolumn Apheresis System

Sponsors & Collaborators

  • Otsuka Frankfurt Research Institute GmbH

    lead INDUSTRY

Principal Investigators

  • Robert Lofberg, Prof. · IBD-unit, Dept. of Gastroenterology, HMQ Sophia Hospital, Stockholm, Sweden

  • Toshifumi Hibi, Prof. · Keio University, Tokyo, Japan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00219414 on ClinicalTrials.gov